Increasing patient awareness of ketoacidosis with gliflozins

Abstract

While SGLT2 inhibitors are generally well tolerated, their use has been associated with cases of ketoacidosis. It is therefore important to make patients aware of what steps they can take to minimise the risk of this potentially serious adverse effect.